Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 7.13
- Piotroski Score 7.00
- Grade Outperform
- Symbol (MEDP)
- Company Medpace Holdings, Inc.
- Price $342.76
- Changes Percentage (1.48%)
- Change $5.01
- Day Low $338.75
- Day High $346.50
- Year High $459.77
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/21/2024
- Fiscal Year End N/A
- Average Stock Price Target $435.00
- High Stock Price Target $469.00
- Low Stock Price Target $345.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $9.80
- Trailing P/E Ratio 40.94
- Forward P/E Ratio 40.94
- P/E Growth 40.94
- Net Income $282.81 M
Income Statement
Quarterly
Annual
Latest News of MEDP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
UK's National Crime Agency says it is 'not scared' of PPE Medpro's lawyers
The National Crime Agency is investigating PPE Medpro, a company linked to Michelle Mone's husband, for suspected criminal offenses in PPE procurement during the pandemic. The agency is determined to ...
By The Guardian | 1 month ago -
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Despite a recent stock decline, Medpace Holdings (NASDAQ:MEDP) shows strong financials, with a 44% Return on Equity (ROE) indicating efficient capital reinvestment. The company's impressive ROE and ea...
By Yahoo! Finance | 1 month ago -
Medpace Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Medpace Holdings, Inc. saw a drop in stock price post their second-quarter report, despite positive results. Analysts expect revenue growth and an increase in earnings per share. The consensus price t...
By Yahoo! Finance | 2 months ago